OptiBiotix Health PLC (AIM:OPTI) shares jumped 13.5% to 5.68p after the company announced a June shareholder event in London to demonstrate its SweetBiotix sugar-substitute technology.
Management plans to provide updates on the commercial development and market strategy for its product portfolio, according to a company statement.
The planned demonstration follows a manufacturing breakthrough announced in November 2025, which OptiBiotix said resulted in higher production yields of a purer, better-tasting product at a lower cost. The event is open to existing shareholders and prospective investors, who have been asked to register online.
The showcase is part of a broader strategy to accelerate the commercialisation of its technologies and increase engagement with investors. OptiBiotix is targeting the growing functional foods and nutrition market with its SweetBiotix range as a health-focused alternative to traditional sugar.
The positive market reaction comes despite continued financial pressure on the company, which includes ongoing losses and cash burn. Technical indicators for the stock also remain weak, reflecting a prolonged downward price trend, although the company continues to benefit from a debt-free balance sheet.
OptiBiotix Health is a life sciences company developing microbiome-based ingredients aimed at managing health conditions, with a portfolio that includes brands like SlimBiome and WellBiome, alongside interests in skincare and probiotics.
The event's success could be crucial for strengthening investor confidence in the product's commercial potential. Investors will be watching for specific details on the market strategy and commercial rollout during the June presentation.
This article is for informational purposes only and does not constitute investment advice.
